Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?

Immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder featured by increased platelet destruction and deficient megakaryocyte maturation. First-line treatments include corticosteroids, intravenous immunoglobulin and intravenous anti-D immunoglobulin. Second-line treatments consist...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yue, Shi, Huiping, Liu, Hong, Zhou, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393521/
https://www.ncbi.nlm.nih.gov/pubmed/36003388
http://dx.doi.org/10.3389/fimmu.2022.953716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393521/
https://www.ncbi.nlm.nih.gov/pubmed/36003388
http://dx.doi.org/10.3389/fimmu.2022.953716

Ejemplares similares